Tadalafil Mylan

Quick links

Choose a section

Quick links to important sections

Advertisements

Tadalafil Mylan

Selected form

Advertisements
Advertisements
Advertisements

Overview of Tadalafil Mylan

Tadalafil Mylan is a generic, synthetic prescription medicine containing the active substance Tadalafil. It is classified pharmacologically as a Phosphodiesterase type 5 (PDE5) inhibitor and is used to support biological functions that require improved, sustained blood flow by relaxing specific smooth muscle tissue.


Property Description
Active ingredient Tadalafil (International Nonproprietary Name)
Form Film-coated tablet
Pharmacological class Phosphodiesterase type 5 (PDE5) Inhibitor
General purpose Promotes localized vasodilation and increased blood flow
Origin Synthetic chemical compound
Manufacturer/Type Mylan (Generic equivalent)

Tadalafil Mylan: Definition and Pharmacological Classification

Tadalafil Mylan is a synthetic, prescription-only generic drug containing the established active ingredient, Tadalafil (INN). This medication is classified as a selective Phosphodiesterase type 5 (PDE5) inhibitor, a classification recognized for its role in modifying vascular response.

As a generic product manufactured by Mylan, it is required to demonstrate bioequivalence to the original reference brand, confirming it delivers the same pharmacological action. Tadalafil is characterized within its class by an extended therapeutic window compared to other PDE5 inhibitors, providing sustained support for vascular function.


Composition, Origin, and Drug Form

The core component of the medication is Tadalafil, which is wholly synthetic in origin and not naturally derived. The structure of Tadalafil is chemically characterized as a complex pyrazinopyridoindole derivative, which dictates its high selective action.

Tadalafil Mylan is prepared as a single-component product and supplied for oral administration in the form of a film-coated tablet. The final dosage unit consists of the active substance Tadalafil alongside necessary solid pharmaceutical excipients. These are inactive materials, such as lactose monohydrate and binding agents, required for stability and effective absorption.


General Purpose of the Tadalafil Mechanism

The general purpose of this medicine stems from its ability to enhance circulation in certain tissues. This action is achieved through selective PDE5 inhibition, which sustains levels of the natural messenger molecule, cGMP (cyclic Guanosine Monophosphate).

The resulting physiological effect is the relaxation of smooth muscles within specific blood vessels, promoting vasodilation and improved local blood flow. This enhanced circulation supports biological processes reliant upon an effective and persistent vascular response.

Regulatory References

  1. Tadalafil Mylan EPAR - Summary for the public
  2. Tadalafil - StatPearls (NIH)
Advertisements

What side effects are possible with Tadalafil Mylan?

Possible Side Effects and Safety Information

The safety profile of Tadalafil, the active ingredient in Tadalafil Mylan, outlines potential adverse reactions categorized by frequency and the body system affected, as established in official regulatory documents. The most commonly reported effects often relate to the medicine’s core function as a vasodilator.

Official Adverse Reaction Frequencies

Adverse reactions are classified according to incidence observed in clinical studies:

  • Very Common / Common: Headache and dyspepsia (indigestion) are frequently documented.
  • Common: Includes musculoskeletal pain such as back pain and myalgia, alongside flushing and nasal congestion.
  • Uncommon: Reactions such as dizziness, blurred vision, hypotension (low blood pressure), and hypertension (high blood pressure) are noted less frequently.

Serious Adverse Reactions and Restrictions

Official labels document rare, but clinically serious, adverse reactions. These include sudden loss of vision (such as Non-arteritic Anterior Ischaemic Optic Neuropathy or NAION), Priapism (a prolonged erection lasting more than four hours), and serious cardiovascular events like stroke or myocardial infarction, often reported in patients with pre-existing risk factors.

Usage is contraindicated with any form of organic nitrates or nitric oxide donors due to the high risk of severe, life-threatening hypotension. Furthermore, official safety constraints necessitate caution and potential dose adjustments for patients with severe renal or hepatic impairment due to altered drug exposure.

Certain musculoskeletal effects, like back pain, typically begin 12 to 24 hours after dosing and usually resolve within 48 hours, a time-related pattern noted in the official safety summary.

Advertisements

Overdose and Emergency Response

High doses of Tadalafil, such as those administered in clinical trials (up to 500 mg), have been associated with increased severity of common documented adverse events. These manifestations of potential overdose include headache, dyspepsia, back pain, myalgia (muscular aches), nasal congestion, and facial flushing.

When Immediate Medical Help is Required

Regulators explicitly mandate that patients seek immediate medical assistance for an erection lasting four hours or longer (priapism), as this condition can result in irreversible damage to the erectile tissue if not promptly treated. Patients are also instructed to stop the medication and seek prompt medical attention in the event of sudden loss of vision or sudden decrease or loss of hearing, as these are serious adverse events documented in the prescribing information.

Overdose Management and Constraints

For Tadalafil overdose, the official protocol is to implement standard supportive measures, as no specific antidote is known. Furthermore, regulatory documents note that haemodialysis contributes negligibly to tadalafil elimination.

In the context of overdose risk, Tadalafil exposure is officially documented as increased in patients with severe renal impairment.

Advertisements

Therapeutic Uses of Tadalafil Mylan

The active ingredient in Tadalafil Mylan is associated with therapeutic uses that address several domains of symptomatic support. The medicine is commonly used to help with conditions characterized by periods of heightened symptoms that interfere with daily functioning. The primary therapeutic domains include assisting with symptoms related to Erectile Dysfunction (ED), supporting the management of discomfort associated with Benign Prostatic Hyperplasia (BPH), and offering supportive management for Pulmonary Arterial Hypertension (PAH).

Managing Symptoms and Benefits

Tadalafil Mylan is applied in clinical settings that involve acute or unstable symptom patterns. It supports patients during episodes of heightened discomfort by assisting with managing symptoms that create noticeable functional strain. The medication is considered relevant when short-term symptomatic assistance is needed. This supports general well-being during symptomatic phases. It contributes to easing the overall symptom load, allowing patients to cope more steadily with symptom fluctuations.


Quick Fact: Supportive Role

The medication is relevant in contexts marked by increased systemic burden or tension, and helps ease the overall symptom burden associated with conditions like BPH and PAH.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile for Tadalafil Mylan

Tadalafil Mylan is officially allowed for use only in the adult population ( mathbfge 18 years ) for approved indications. Use in the pediatric population is not established and generally not recommended by regulatory authorities.

Populations Who Must Not Use

The medicine is contraindicated in several specific populations. Patients must not use Tadalafil Mylan if they are simultaneously taking any form of organic nitrate or Guanylate Cyclase (GC) Stimulators (like Riociguat). Contraindication also applies to individuals with a known hypersensitivity to the active substance. Absolute prohibitions include recent cardiovascular events, such as a Myocardial Infarction (MI) within the last 90 days or a Stroke within the last six months. Patients with a history of vision loss due to Non-Arteritic Ischemic Optic Neuropathy (NAION) are also excluded.

Use Restrictions and Limitations

Eligibility is restricted by organ function. The medicine is not recommended for patients with Severe Hepatic Impairment (Child-Pugh Class C) or those with Severe Renal Impairment (CrCl mathbf<30 mL/min) for once-daily dosing. Caution is advised for patients with conditions that predispose to priapism, such as sickle-cell anemia or Peyronie’s disease. For reproductive safety, use in pregnancy is not recommended.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

It is essential to inform your healthcare provider about all medicines you are taking, including prescription, over-the-counter drugs, vitamins, and herbal supplements. Tadalafil Mylan can interact with numerous agents, potentially leading to serious adverse effects.


Contraindicated Combinations

Tadalafil Mylan must not be taken with medicines containing nitrates (e.g., nitroglycerin, isosorbide dinitrate, amyl nitrite) used for chest pain (angina), or with guanylate cyclase stimulators (e.g., riociguat) for pulmonary hypertension. Combining these with Tadalafil Mylan can cause a sudden, severe, and potentially life-threatening drop in blood pressure (hypotension).


Use with Caution

Other medicines may increase the risk of side effects or reduce the effectiveness of Tadalafil Mylan. Close monitoring or dose adjustment may be necessary when taken with:

  • Alpha-blockers (e.g., tamsulosin, doxazosin) used for high blood pressure or enlarged prostate (BPH). The combination can lead to a significant drop in blood pressure.
  • Other blood pressure medicines (antihypertensives), which may have additive blood pressure-lowering effects.
  • Certain protease inhibitors (e.g., ritonavir) and oral antifungals (e.g., ketoconazole, itraconazole), which can increase tadalafil levels in the blood, raising the risk of side effects.
  • Certain antibiotics (e.g., erythromycin, clarithromycin) and other PDE5 inhibitors (e.g., sildenafil, vardenafil). Simultaneous use of other PDE5 inhibitors is generally avoided.
  • Certain anti-seizure medicines (e.g., carbamazepine, phenytoin), which may decrease tadalafil levels, reducing its effectiveness.

Other Interactions

  • Alcohol intake should be limited, as it can contribute to a drop in blood pressure when combined with Tadalafil Mylan.
  • Grapefruit juice may increase the level of tadalafil in the body, which could increase the risk of side effects.
Advertisements

Mechanism of Action

How Tadalafil Mylan Works

Tadalafil is classified as a phosphodiesterase type 5 (PDE5) inhibitor. Its primary biological target is the PDE5 enzyme, which is localized predominantly within the smooth muscle cells of the corpus cavernosum and arterial walls throughout the body. The drug establishes an inhibitory interaction with this specific enzyme.

The inhibition of PDE5 prevents the enzymatic hydrolysis of cyclic guanosine monophosphate (cGMP), a key second messenger molecule. By modulating this pathway, Tadalafil effectively preserves and increases the intracellular concentration of cGMP within the smooth muscle cells.

The elevated cGMP concentration then activates downstream signaling cascades, ultimately leading to a decrease in intracellular calcium. This sequence causes the relaxation of smooth muscle tissue in the arterial walls (vasorelaxation), resulting in vasodilation (widening of the blood vessels). This physiological effect is the final output of the drug's mechanism.

Advertisements

Dosage and Administration Information

How to Use Tadalafil Mylan

This section outlines the high-level principles for the administration and dosage of Tadalafil.


Official Administration and Dosage Patterns

Tadalafil Mylan is a film-coated tablet intended for oral administration. The use of this medicine is defined by two primary patterns, with a maximum dose frequency of once per day for all indications. The tablet may be taken with or without food.

Use Pattern Indication Dosing Regimen Administration Timing
As Needed Erectile Dysfunction (ED) Starting dose: 10 mg; Max dose: 20 mg Taken at least 30 minutes prior to anticipated activity.
Once Daily ED, Benign Prostatic Hyperplasia (BPH) Fixed dose: 5 mg (2.5 mg starting for ED only) Taken at approximately the same time every day.
Once Daily Pulmonary Arterial Hypertension (PAH) Fixed dose: 40 mg Taken once daily. Dividing the dose is not recommended.

Key Procedural and Population Constraints

Official instructions stipulate that the film-coated tablet must be swallowed whole and should not be crushed or chewed. The higher, on-demand doses (10 mg or 20 mg) are not intended for continuous daily use; the appropriateness of continued use for once-daily regimens must be periodically assessed.

In specific populations, caution is advised regarding regimen choice: for patients with severe renal or hepatic impairment, the once-daily regimen is not recommended, and the maximum dose for on-demand use may be restricted to 10 mg or lower. Conversely, no dose adjustments are required for older adults based on age alone.

Advertisements

Recent Clinical Evidence

Tadalafil Mylan: Recent Clinical Evidence

Clinical research has focused on the use of Tadalafil for treating Erectile Dysfunction (ED) and the symptoms of Benign Prostatic Hyperplasia (BPH).


Efficacy in Erectile Dysfunction

Multiple randomized, placebo-controlled trials have evaluated the effect of Tadalafil taken both as needed and once daily in men with ED of various severities and causes. These studies primarily assessed outcomes using validated measures such as the International Index of Erectile Function (IIEF-EF) domain score and the Sexual Encounter Profile (SEP) diary questions.

  • Results showed that Tadalafil was associated with improved scores on these measures compared to placebo. Depending on the dose, trials reported that up to 84% of men found an improvement in their erections. The effect of Tadalafil can last for up to 36 hours after dosing, which offers flexibility in treatment timing.

Efficacy in Benign Prostatic Hyperplasia (BPH)

Studies have also examined Tadalafil 5 mg once daily for treating Lower Urinary Tract Symptoms (LUTS) associated with BPH. Integrated analyses of clinical data suggest that Tadalafil is associated with a reduction in the International Prostate Symptom Score (IPSS), including both voiding (e.g., weak stream) and storage (e.g., urgency) subscores, compared to placebo. This effect may be observed as early as one week after starting treatment and becomes statistically significant by four weeks in some trials.


Safety and Tolerability Profile

Across clinical trials for both ED and BPH, Tadalafil demonstrated an adverse event profile consistent with the PDE5 inhibitor class. The most frequently reported adverse events include headache, dyspepsia (indigestion), back pain, and myalgia (muscle aches). While generally considered a well-tolerated treatment, patients in trials experienced these side effects at a higher incidence than those on placebo. Research continues to monitor the long-term safety profile of Tadalafil.

Key Studies & References

  1. Tadalafil Summary of Product Characteristics (SmPC) / Labeling
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tadalafil Mylan (FAQ)


Q: Does taking Tadalafil Mylan require sexual stimulation to be effective?

Official product information states that for the treatment of erectile dysfunction, sexual stimulation is necessary for the medicine to work. Tadalafil facilitates the body's natural response to arousal but does not work in the absence of that stimulation.


Q: What is the reason for Tadalafil being referred to as 'the weekend pill'?

This popular term is often used by patients to describe the medication's characteristic duration of action. Studies and official information indicate that the effect can last for up to 36 hours after taking the tablet, which is associated with flexibility in treatment timing.


Q: Is Tadalafil Mylan proven to be effective for men with erectile dysfunction caused by diabetes?

Clinical research examining Tadalafil's effectiveness for erectile dysfunction included specific patient groups, such as men with diabetes. Clinical data indicated that the medicine was associated with improved measures of erectile function in this specific subgroup.


Q: Why is Tadalafil Mylan generally not recommended for patients with low blood pressure?

Official guidance highlights the necessity of informing the healthcare provider about pre-existing low blood pressure (hypotension) before use. Tadalafil can decrease blood pressure, and official labels caution that the combination may lead to further significant drops.


Q: Do generic Tadalafil Mylan tablets have different inactive ingredients compared to Cialis?

Regulatory standards require generic Tadalafil Mylan to be bioequivalent to the original brand-name product, meaning the active ingredient works the same way. However, the inactive ingredients, also called excipients, can and often do vary between generic and brand-name tablets.


Q: Is there research evidence supporting the long-term use of Tadalafil Mylan?

Official clinical trials have investigated the safety and tolerability profile of Tadalafil over extended periods. Studies assessed the drug when taken for up to 18 to 24 months, indicating it demonstrated an acceptable tolerability profile over this time frame.


Q: What happens if a patient misses a scheduled daily dose of Tadalafil Mylan?

Official guidance on a missed daily dose varies depending on the medical condition being treated. Guidelines for certain conditions instruct the patient to take the dose as soon as it is remembered. For pulmonary hypertension, official instructions may state to take the dose within a certain timeframe, or otherwise skip it.


Q: Does Tadalafil Mylan protect against sexually transmitted diseases?

According to regulatory patient information, this medicine does not offer any protection against sexually transmitted diseases (STDs). This includes preventing the transmission of HIV or acting as a form of male birth control.


Q: What are the symptoms of a serious allergic reaction to Tadalafil?

Symptoms of a serious allergic reaction are listed in official documents as a potential safety concern. These may include a rash, hives, swelling of the lips, tongue, or throat, or difficulty breathing or swallowing.


Q: Is there any research on the effect of Tadalafil on male fertility or sperm concentration?

Regulatory clinical trials have examined the effect of Tadalafil on spermatogenesis, which is the process of sperm development. Clinical data from studies did not observe adverse effects on sperm concentration, count, or reproductive hormones.


Q: What is the official information regarding Tadalafil Mylan's use in women?

Tadalafil is not officially licensed or approved for female sexual dysfunction. However, Tadalafil is approved for the treatment of pulmonary arterial hypertension (PAH) and may be used by both men and women for that specific condition.


Q: Does Tadalafil Mylan carry a warning about sudden decrease or loss of hearing?

Official regulatory bodies have required that a warning be added to the product information regarding sudden decrease or loss of hearing. This is a rare potential adverse event that may sometimes occur alongside ringing in the ears or dizziness.


Q: How quickly does Tadalafil Mylan leave the bloodstream completely?

Pharmacokinetic data from official sources describes the drug's elimination rate using a measurement called the mean half-life. The time for half of the drug's concentration to be eliminated (the half-life) is reported as approximately 17.5 hours in healthy individuals.


Q: What is the official guidance on driving or operating machinery while taking Tadalafil Mylan?

Official guidance indicates that caution is necessary when driving or operating machinery. This guidance is based on the potential of the medicine to affect coordination, reaction time, or judgment until a patient knows how it affects them.


Q: Why is it important for patients to tell doctors they are taking Tadalafil Mylan before emergency care?

Due to the severe risk of low blood pressure (hypotension) if combined with certain heart medications, such as nitrates, official guidance emphasizes communicating use of this medicine to emergency medical personnel, especially if care is needed for a heart problem.

Advertisements

How should Tadalafil Mylan be stored and disposed of?

How to Store and Dispose of Tadalafil Mylan

Tadalafil tablets must be stored at Controlled Room Temperature, typically 20°C to 25°C (68°F to 77°F), with a maximum limit of 30°C. The medicine must be kept away from excess heat, moisture, and light, and kept from freezing. Do not store the tablets in a bathroom.

Container and Safety

Always store the medication in its original container, which should be kept tightly closed to protect the tablets from moisture. Tadalafil Mylan must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal

Unused or expired tablets should be disposed of in accordance with local requirements. The preferred disposal method is through an authorized drug take-back program. Tadalafil is not on the list of medicines recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tadalafil Mylan found in:

A-Z Index: